(Q34746476)

4 August 2017

1 reference

title

Oral adenoviral-based vaccines: historical perspective and future opportunity (English)

1 reference

4 August 2017

1 reference

Sean N Tucker

1

1 reference

4 August 2017

Debora W Tingley

series ordinal

2

1 reference

4 August 2017

Ciaran D Scallan

series ordinal

3

1 reference

4 August 2017

publication date

1 February 2008

1 reference

Expert Review of Vaccines

4 August 2017

published in

1 reference

4 August 2017

volume

7

1 reference

4 August 2017

issue

1

1 reference

4 August 2017

page(s)

25-31

1 reference

Adenovirus vector-based vaccines for human immunodeficiency virus type 1.

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.25

Sensing infection by adenovirus: Toll-like receptor-independent viral DNA recognition signals activation of the interferon regulatory factor 3 master regulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.25

Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999-2004

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.25

Communicability of enteric live adenovirus type 4 vaccine in families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.25

Poliovirus vaccine strains detected in stool specimens of immunodeficient children in South Africa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.25

Biological safety concepts of genetically modified live bacterial vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.25

Demonstration of loss of attenuation and extended field persistence of a live avian metapneumovirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.25

Immunization to protect the US Armed Forces: heritage, current practice, and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.25

Expression of hepatitis B surface antigen with a recombinant adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.25

Recombinant adenovirus induces antibody response to hepatitis B virus surface antigen in hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.25

Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.25

Recombinant adenovirus encoding the HA gene from swine H3N2 influenza virus partially protects mice from challenge with heterologous virus: A/HK/1/68 (H3N2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.25

Intramuscular rather than oral administration of replication-defective adenoviral vaccine vector induces specific CD8+ T cell responses in the gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.25

Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.25

TLRs in the Gut. IV. Negative regulation of Toll-like receptors and intestinal homeostasis: addition by subtraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.25

In vitro and in vivo assessment of adenovirus 41 as a vector for gene delivery to the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.25

Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.25

A chimeric adenovirus vector encoding reovirus attachment protein sigma1 targets cells expressing junctional adhesion molecule 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.25

Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.25

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.25

Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.25

The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.25

Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.25

Enhanced resistance of mice to virulent Japanese B encephalitis virus following inactivated vaccine and poly I:C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.25

Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.25

Immune responses to adenovirus and adeno-associated virus in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.25

Established immunity precludes adenovirus-mediated gene transfer in rat carotid arteries. Potential for immunosuppression and vector engineering to overcome barriers of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.25

Immunogenicity and protection of a recombinant human adenovirus serotype 35-based malaria vaccine against Plasmodium yoelii in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.25

Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.25

Transient immunomodulation with anti-CD40 ligand antibody and CTLA4Ig enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.25

"Stealth" adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.25

Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.25

Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.25

Adenovirus complexed with polyethylene glycol and cationic lipid is shielded from neutralizing antibodies in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.25

Poly (lactic-glycolic) acid copolymer encapsulation of recombinant adenovirus reduces immunogenicity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.25

Specific depletion of human anti-adenovirus antibodies facilitates transduction in an in vivo model for systemic gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.25

A recombinant E1-deleted canine adenoviral vector capable of transduction and expression of a transgene in human-derived cells and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.25

Oral Vaccination of Mice with Adenoviral Vectors Is Not Impaired by Preexisting Immunity to the Vaccine Carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.25

Immune response to neonatal genetic immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.25

Safety and immunogenicity of attenuated Salmonella enterica serovar Typhimurium delivering an HIV-1 Gag antigen via the Salmonella Type III secretion system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.25

Interferon-gamma inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.25

21 January 2018

Identifiers

DOI

10.1586/14760584.7.1.25

1 reference

4 August 2017

1 reference